Pathos was founded to revolutionize precision medicine in cancer by harnessing the power of machine learning to transform drug development. Pathos aims to accelerate traditional oncology approaches based upon a comprehensive and integrated data-first strategy to discover and develop drugs for precise biological pathways. Pathos is currently pursuing co-development and in-licensing opportunities to build a portfolio of clinical stage oncology assets, applying its technology to find the right patients and indications, resulting in a highly improved probability of success and faster time to market.

The founding team built and scaled Tempus Labs, an AI-enabled diagnostics company that has built the world’s largest library of clinical and molecular data and an operating system to make sense of it. Through this experience, the founders have seen how precision medicine can transform lives, yet many patients remain who need better therapies. A new approach is needed to change the paradigm of drug development to rapidly serve these unmet needs, highlighting a unique opportunity for Pathos to pursue. We’re looking for other trailblazers who see the world differently and want to forge this new path with us.

Our team is distributed across the US with hubs in New York and Salt Lake. While we still operate with the agility of a startup, we are scaling to advance our platform.

About the role

We are seeking a highly motivated Business Development Analyst to support our investment and acquisition strategies in the biotech space. The Analyst will be responsible for evaluating investment opportunities through rigorous analytical work, technical diligence, and cross-functional collaboration. This role is ideal for candidates who possess strong analytical skills, knowledge of drug development, an understanding of biotech investment, and a passion for identifying and advancing promising therapeutics. The Business Development Analyst will report to the Director of Corporate Development.

Key responsibilities include:

● Deal Execution: Support all stages of deal execution, including sourcing new deals, preparing investment memos, and conducting due diligence.

● Market Research and Analysis: Conduct comprehensive market research and competitive intelligence to identify high-value drug assets and investment opportunities in oncology.

● Technical Evaluation: Assess the scientific merit and technical feasibility of drug development programs, with a focus on AI-enabled approaches to oncology.

● Due Diligence Support: Conduct thorough scientific, commercial, and regulatory due diligence on potential investments, synthesizing complex information into clear investment recommendations.

● Cross-functional Collaboration: Work with internal teams (scientific, clinical, technical, legal) to integrate diverse perspectives into investment analyses and recommendations.

● Presentation and Communication: Prepare and deliver clear, concise memos, presentations, and reports to senior management.

● Financial Modeling and Analysis: Develop comprehensive financial models to evaluate investment opportunities, including DCF analysis, market sizing, and revenue projections for pharmaceutical assets.

● Conferences and Industry Events: Attend and represent the company at key industry conferences, networking events, and business development forums to identify new opportunities and partnerships.

Who You Are

● Bachelor’s degree in life sciences, business, finance, or a related field (e.g., Bioengineering, Computational Biology). An advanced degree (MD, PhD, or MBA) is preferred.

● 3-5 years of experience in business development, venture capital, consulting, investment banking, or a related field within the biotech/pharmaceutical industry.

● Strong analytical skills, including proficiency in Microsoft tools, and exceptional attention to detail with the ability to manage multiple complex analyses simultaneously.

● Excellent written and verbal communication skills, with the ability to synthesize complex data (e.g., scientific literature, clinical trial data, technical processes) into actionable investment insights for diverse audiences.

● Understanding of the oncology drug development process, from discovery through approval and commercialization.

● Proven ability to identify high-potential investment opportunities and develop thoughtful, evidence-based recommendations.

● Ability to thrive in a fast-paced, dynamic environment and manage multiple priorities.

● Strong collaboration skills and a strategic mindset.

● High level of initiative, self-motivation, and a strong sense of ownership.

Bonus Experience:

● Prior experience in biotech venture capital or investment analysis.

● Familiarity with deal structuring, term sheets, and negotiation strategies in the biotech space.

● A strong network within the biotech and pharmaceutical investment community.

● Experience with AI-driven healthcare or oncology drug development investments.

● Knowledge of regulatory frameworks governing pharmaceutical development (FDA, EMA).

● Background in computational biology, bioinformatics, or AI/ML applications in healthcare.